You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
AstraZeneca
Express Scripts
Harvard Business School
Moodys
McKesson

Last Updated: August 11, 2020

DrugPatentWatch Database Preview

SIMPONI Drug Profile

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Recent Clinical Trials for SIMPONI

Identify potential brand extensions & biosimilar entrants

SponsorPhase
Bio-Thera SolutionsPhase 1
Johnson & Johnson Private LimitedPhase 4
Juvenile Diabetes Research FoundationEarly Phase 1

See all SIMPONI clinical trials

Recent Litigation for SIMPONI

Identify key patents and potential future biosimilar entrants

District Court Litigation
Case NameDate
ABBVIE INC. v. SANDOZ INC.2018-08-10
Celgene Corporation v. Aurobindo Pharma Limited2018-07-06
CELGENE CORPORATION v. EMCURE PHARMACEUTICALS LTD.2018-06-28

See all SIMPONI litigation

PTAB Litigation
PetitionerDate
2017-12-20

See all SIMPONI litigation

Pharmacology for SIMPONI

Patent Text Search: US Patents for SIMPONI

These patents were identified by searching patent claims

Supplementary Protection Certificates for SIMPONI

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
C02041177/01 Switzerland   Start Trial PRODUCT NAME: SARILUMAB; REGISTRATION NO/DATE: SWISSMEDIC-ZULASSUNG 66424 20.04.2018
1790062-2 Sweden   Start Trial PRODUCT NAME: SARILUMAB; REG. NO/DATE: EU/1/17/1196 20170627
301035 Netherlands   Start Trial PRODUCT NAME: UPADACITINIB OF EEN FARMACEUTISCH AANVAARDBAAR ZOUT DAARVAN; REGISTRATION NO/DATE: EU/1/19/1404 20191218
LUC00050 Luxembourg   Start Trial PRODUCT NAME: SARILUMAB ET SES DERIVES PHARMACEUTIQUEMENT ACCEPTABLES (KEVZARA); AUTHORISATION NUMBER AND DATE: EU/1/17/1196 20170627
PA2017038,C2041177 Lithuania   Start Trial PRODUCT NAME: SARILUMABAS; REGISTRATION NO/DATE: EU/1/17/1196 20170623
>Supplementary Protection Certificate >SPC Country >SPC Expiration >SPC Description

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Colorcon
Moodys
Harvard Business School
Medtronic
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.